102 related articles for article (PubMed ID: 29632908)
1. DNA-based nanoscaffolds as vehicles for 5-fluoro-2'-deoxyuridine oligomers in colorectal cancer therapy.
Jorge AF; Aviñó A; Pais AACC; Eritja R; Fàbrega C
Nanoscale; 2018 Apr; 10(15):7238-7249. PubMed ID: 29632908
[TBL] [Abstract][Full Text] [Related]
2. Parallel G-quadruplex Structures Increase Cellular Uptake and Cytotoxicity of 5-Fluoro-2'-deoxyuridine Oligomers in 5-Fluorouracil Resistant Cells.
Clua A; Fàbrega C; García-Chica J; Grijalvo S; Eritja R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33804620
[TBL] [Abstract][Full Text] [Related]
3. Defined covalent attachment of three cancer drugs to DNA origami increases cytotoxicity at nanomolar concentration.
Navarro N; Aviñó A; Domènech Ò; Borrell JH; Eritja R; Fàbrega C
Nanomedicine; 2024 Jan; 55():102722. PubMed ID: 38007069
[TBL] [Abstract][Full Text] [Related]
4. [Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].
Katona C; Timár F; Oláh J; Bocsi J; Budai B; Otvös L; Kralovánszky J
Magy Onkol; 2004; 48(3):243-51. PubMed ID: 15520875
[TBL] [Abstract][Full Text] [Related]
5. SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer.
Sun P; Zhang N; Tang Y; Yang Y; Chu X; Zhao Y
Int J Nanomedicine; 2017; 12():2657-2672. PubMed ID: 28435250
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation.
Fanciullino R; Giacometti S; Mercier C; Aubert C; Blanquicett C; Piccerelle P; Ciccolini J
Br J Cancer; 2007 Oct; 97(7):919-26. PubMed ID: 17848948
[TBL] [Abstract][Full Text] [Related]
7. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
8. New 3'-O-aromatic acyl-5-fluoro-2'-deoxyuridine derivatives as potential anticancer agents.
Szymańska-Michalak A; Wawrzyniak D; Framski G; Kujda M; Zgoła P; Stawinski J; Barciszewski J; Boryski J; Kraszewski A
Eur J Med Chem; 2016 Jun; 115():41-52. PubMed ID: 26994842
[TBL] [Abstract][Full Text] [Related]
9. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line.
Han Y; Bu LM; Ji X; Liu CY; Wang ZH
Chin J Dig Dis; 2005; 6(2):82-6. PubMed ID: 15904426
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T
Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352
[TBL] [Abstract][Full Text] [Related]
11. DNA origami as a carrier for circumvention of drug resistance.
Jiang Q; Song C; Nangreave J; Liu X; Lin L; Qiu D; Wang ZG; Zou G; Liang X; Yan H; Ding B
J Am Chem Soc; 2012 Aug; 134(32):13396-403. PubMed ID: 22803823
[TBL] [Abstract][Full Text] [Related]
12. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers.
Varshosaz J; Hassanzadeh F; Sadeghi H; Andalib S
Eur J Med Chem; 2012 Aug; 54():429-38. PubMed ID: 22687440
[TBL] [Abstract][Full Text] [Related]
14. Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells.
Lee KC; Lin CT; Chang SF; Chen CN; Liu JL; Huang WS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117108
[TBL] [Abstract][Full Text] [Related]
15. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
Chen L; She X; Wang T; He L; Shigdar S; Duan W; Kong L
Nanoscale; 2015 Sep; 7(33):14080-92. PubMed ID: 26242620
[TBL] [Abstract][Full Text] [Related]
16. Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells.
Wen C; Huang L; Chen J; Lin M; Li W; Lu B; Rutnam ZJ; Iwamoto A; Wang Z; Yang X; Liu H
Int J Oncol; 2015 Nov; 47(5):1663-71. PubMed ID: 26397804
[TBL] [Abstract][Full Text] [Related]
17. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
[TBL] [Abstract][Full Text] [Related]
18. Epigenomics alternations and dynamic transcriptional changes in responses to 5-fluorouracil stimulation reveal mechanisms of acquired drug resistance of colorectal cancer cells.
Shen Y; Tong M; Liang Q; Guo Y; Sun HQ; Zheng W; Ao L; Guo Z; She F
Pharmacogenomics J; 2018 Jan; 18(1):23-28. PubMed ID: 28045128
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
20. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
